Justin B. Klee
Director & Co-Chief Executive Officer
SEC EDGAR ↗Director & Co-Chief Executive Officer at Amylyx Pharmaceuticals, Inc., filing insider transactions on 2026-09-10.
Total Purchases
—
0 transactions
Total Sales
$980K
2 transactions
Companies Traded
1
2 total filings
Active Since
2026-09-10
Last: 2026-09-10
Other Reporting Insiders at Amylyx Pharmaceuticals, Inc.
Transaction History
| Date | Ticker | Type | Shares | Price | Value | Owned After | |
|---|
| 2026-09-10 | AMLX | Sale | 1,439 | $33.16 | $48K | 3.61M | SEC ↗ |
| 2026-09-10 | AMLX | Sale | 29.0K | $32.13 | $933K | 3.61M | SEC ↗ |
Director & Co-Chief Executive Officer
Justin B. Klee (Amylyx Pharmaceuticals, Inc.) Insider Trades | Tormere